Healthcare provider profile · identity verified

Edward W Boyts, MD

Family Practice · NEW PARIS, IN · NPI 1750351086

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	368	113
Levothyroxine Sodium	Levothyroxine Sodium	250	65
Gabapentin	Gabapentin	228	59
Amlodipine Besylate	Amlodipine Besylate	222	72
Metoprolol Succinate	Metoprolol Succinate	190	53
Omeprazole	Omeprazole	177	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	144	31
Alprazolam	Alprazolam	140	31
Pantoprazole Sodium	Pantoprazole Sodium	126	33
Lisinopril	Lisinopril	116	33
Meloxicam	Meloxicam	113	35
Tamsulosin Hcl	Tamsulosin Hcl	110	36
Losartan Potassium	Losartan Potassium	108	33
Montelukast Sodium	Montelukast Sodium	108	25
Allopurinol	Allopurinol	107	28
Clopidogrel	Clopidogrel Bisulfate	103	31
Metformin Hcl	Metformin Hcl	102	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	95	11
Trazodone Hcl	Trazodone Hcl	95	26
Pregabalin	Pregabalin	89	14
Furosemide	Furosemide	85	29
Simvastatin	Simvastatin	83	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	83	23
Rosuvastatin Calcium	Rosuvastatin Calcium	81	23
Tramadol Hcl	Tramadol Hcl	79	20
Duloxetine Hcl	Duloxetine Hcl	76	22
Escitalopram Oxalate	Escitalopram Oxalate	76	20
Metoprolol Tartrate	Metoprolol Tartrate	76	23
Alendronate Sodium	Alendronate Sodium	75	19
Eliquis	Apixaban	75	15
Zolpidem Tartrate	Zolpidem Tartrate	75	21
Ozempic	Semaglutide	70	11
Methylprednisolone	Methylprednisolone	64	53
Warfarin Sodium	Warfarin Sodium	63	17
Sertraline Hcl	Sertraline Hcl	59	18
Bupropion Xl	Bupropion Hcl	58	16
Carvedilol	Carvedilol	52	12
Valsartan	Valsartan	51	15
Olmesartan Medoxomil	Olmesartan Medoxomil	48	12
Hydrochlorothiazide	Hydrochlorothiazide	47	14
Potassium Chloride	Potassium Chloride	47	16
Oxybutynin Chloride Er	Oxybutynin Chloride	46	13
Azithromycin	Azithromycin	43	31
Metformin Hcl Er	Metformin Hcl	42	12
Glipizide	Glipizide	41	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	11
Pioglitazone Hcl	Pioglitazone Hcl	41	12
Pravastatin Sodium	Pravastatin Sodium	41	11
Prednisone	Prednisone	41	30
Spironolactone	Spironolactone	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	11
Famotidine	Famotidine	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	40	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	11
Finasteride	Finasteride	38	12
Morphine Sulfate Er	Morphine Sulfate	38	suppressed
Mounjaro	Tirzepatide	37	suppressed
Ondansetron Odt	Ondansetron	37	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	30
Celecoxib	Celecoxib	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	27
Doxycycline Hyclate	Doxycycline Hyclate	34	29
Amoxicillin	Amoxicillin	30	25
Lorazepam	Lorazepam	30	suppressed
Temazepam	Temazepam	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	11
Glipizide Er	Glipizide	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	16
Buspirone Hcl	Buspirone Hcl	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	11
Fluconazole	Fluconazole	21	11
Irbesartan	Irbesartan	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Risperidone	Risperidone	21	suppressed
Estradiol	Estradiol	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	15
Sotalol	Sotalol Hcl	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Digoxin	Digoxin	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	15
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Atenolol	Atenolol	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	suppressed
Cephalexin	Cephalexin	16	14
Ezetimibe	Ezetimibe	16	suppressed
Glycopyrrolate	Glycopyrrolate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Colchicine	Colchicine	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Methylphenidate Er	Methylphenidate Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Cefdinir	Cefdinir	12	11
Cefuroxime	Cefuroxime Axetil	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error